Soligenix, Inc., a US-based late-stage biopharmaceutical company, has set its sights on developing and marketing products to address rare diseases. The company is currently divided into two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment is dedicated to the development of SGX301 (HyBryte), a pioneering photodynamic therapy designed for the treatment of cutaneous T-cell lymphoma. This segment is also in the process of creating SGX942, which uses innate defense regulator technology and is aimed at treating inflammatory diseases, such as oral mucositis in head and neck cancer. The Specialized BioTherapeutics segment also offers its proprietary formulations of oral beclomethasone 17,21-dipropionate in SGX203, which caters to pediatric Crohn’s disease, and SGX302, which is undergoing Phase I/II clinical trials for mild-to-moderate psoriasis. The Public Health Solutions segment of Soligenix, Inc. is currently developing several potential remedies for infectious diseases, including RiVax, a vaccine candidate for ricin toxicity that has completed Phase Ia and Ib clinical trials. SGX943 is another therapeutic candidate currently in its pre-clinical stages, aiming to address antibiotic-resistant and emerging infectious diseases. The company’s ThermoVax technology, also in pre-clinical stages, is focused on thermostabilizing vaccines, and the CiVax vaccine candidate seeks to prevent COVID-19. Since changing its name from DOR BioPharma, Inc. in 2009, Soligenix, Inc. has continued to pursue its mission by drawing on the wealth of experience gained since it was incorporated in 1987. Headquartered in Princeton, New Jersey, the company is primed to meet the needs of people suffering from rare diseases and emerging infections.
Soligenix, Inc.'s ticker is SNGX
The company's shares trade on the NASDAQ stock exchange
They are based in Princeton, New Jersey
There are 11-50 employees working at Soligenix, Inc.
It is https://www.soligenix.com/
Soligenix, Inc. is in the Healthcare sector
Soligenix, Inc. is in the Biotechnology industry
The following five companies are Soligenix, Inc.'s industry peers: